1.Clinical evaluation of the shape memory alloy embracing fixator for trea tment of clavicular fractures
Jianfeng SUN ; Waer AINI ; Lei DENG
Chinese Journal of Orthopaedic Trauma 2002;0(02):-
Objective To study the effect and indication of the shape memory alloy(SMA)embracing fixator for treatment of clavicular fracture.Methods Thirty-six cases with clavicular fr acture were treated with SMA embracing fixator,of which 33we re middle third fracture and 3were between middle and lateral fracture.Results Thirty-five cases were followed up f or an average of 16months(from 8to 20months)and the average clinical healing was 2.8months(between 2and 4months).The results were evaluated accordi ng to Han Pingliang' s criteria and showed that 22cases wa s excellent,and 11cases was good.The excellent and good rate was 94.3percent.Conclusion The internal fixation with SMA embra cing fixator is less traumatic,stab le,safly effective to treat clavicular fracture.It is recommendable for treatment of clavicu lar fracture located in the middle an d proximal.The SMA embracing fixator must be pru dently used when the fracture is in th e curvature of clavicle.
2.Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro.
Chao-ju XIAO ; Xian-rong QI ; Waer AINI ; Shu-li WEI
Acta Pharmaceutica Sinica 2003;38(2):133-137
AIMTo prepare cisplatin multivesicular liposomes with high encapsulation efficiency and sustained-release character, and compare the release characteristics with conventional liposomes prepared by reverse-phase evaporation method.
METHODSCisplatin multivesicular liposomes were prepared using multiple emulsion method. The concentrations of cisplatin and lipids in the liposomes were measured by flameless atomic absorbance spectroscopy (FAAS) and phosphalipid enzyme reagent method, respectively. The encapsulation efficiency, size and release of the cisplatin from the liposomes were studied in vitro.
RESULTSThe mean diameter of cisplatin multivesicular liposomes was (16.6 +/- 1.0) micron. The encapsulation efficiency of cisplatin was more than 80%. The release profile in vitro fitted with a first-order equation. The releasing t1/2 of cisplatin multivesicular liposomes is 37.7 h, which is 8.4 that of conventional liposomes. Co-membrane stabilizer has remarkable stabilizing effect on the multivesicular liposomal membrane confirmed by differential scattering calorimetry (DSC).
CONCLUSIONThe cisplatin multivesicular liposomes showed high encapsulation efficiency and sustained-release character.
Antineoplastic Agents ; administration & dosage ; analysis ; Cisplatin ; administration & dosage ; analysis ; Delayed-Action Preparations ; Drug Carriers ; Drug Delivery Systems ; Liposomes ; Particle Size ; Technology, Pharmaceutical ; methods